Shunqi Yan

2.4k total citations
26 papers, 1.1k citations indexed

About

Shunqi Yan is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Shunqi Yan has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 11 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Shunqi Yan's work include Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (5 papers) and Fluorine in Organic Chemistry (4 papers). Shunqi Yan is often cited by papers focused on Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (5 papers) and Fluorine in Organic Chemistry (4 papers). Shunqi Yan collaborates with scholars based in United States, Norway and China. Shunqi Yan's co-authors include Jim Zhen Wu, Zhi Hong, Robert A. Moss, Gary Larson, T.C. Appleby, Robert Hamatake, Nanhua Yao, Karsten Krogh‐Jespersen, Baoming Huang and Shuqun Sheng and has published in prestigious journals such as Journal of the American Chemical Society, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Shunqi Yan

26 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shunqi Yan 432 334 278 157 113 26 1.1k
E H Ulm 281 0.7× 1.1k 3.2× 34 0.1× 117 0.7× 220 1.9× 47 1.6k
Christine Luong 387 0.9× 549 1.6× 28 0.1× 25 0.2× 262 2.3× 19 1.5k
Weige Zhang 1.1k 2.4× 554 1.7× 75 0.3× 42 0.3× 175 1.5× 104 1.8k
F. George Njoroge 836 1.9× 853 2.6× 91 0.3× 22 0.1× 180 1.6× 101 2.5k
Sankar Bhattacharyya 123 0.3× 422 1.3× 82 0.3× 38 0.2× 231 2.0× 75 1.1k
Antonietta Di Cristina 587 1.4× 349 1.0× 60 0.2× 36 0.2× 97 0.9× 26 1.0k
Weiren Xu 332 0.8× 902 2.7× 28 0.1× 20 0.1× 315 2.8× 98 1.5k
Rayomand J. Unwalla 395 0.9× 428 1.3× 69 0.2× 23 0.1× 210 1.9× 34 1.1k
Kunal Nepali 966 2.2× 645 1.9× 50 0.2× 18 0.1× 106 0.9× 34 1.5k
Torsten Herbertz 386 0.9× 446 1.3× 44 0.2× 7 0.0× 121 1.1× 28 1.1k

Countries citing papers authored by Shunqi Yan

Since Specialization
Citations

This map shows the geographic impact of Shunqi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunqi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunqi Yan more than expected).

Fields of papers citing papers by Shunqi Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunqi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunqi Yan. The network helps show where Shunqi Yan may publish in the future.

Co-authorship network of co-authors of Shunqi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Shunqi Yan. A scholar is included among the top collaborators of Shunqi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunqi Yan. Shunqi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somwar, Romel, James D. Joseph, Roger S. Smith, et al.. (2016). Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations. Clinical Cancer Research. 23(12). 2981–2990. 49 indexed citations
2.
Popovici-Müller, Janeta, Jeffrey O. Saunders, Francesco G. Salituro, et al.. (2012). Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo. ACS Medicinal Chemistry Letters. 3(10). 850–855. 160 indexed citations
3.
Yan, Shunqi, et al.. (2010). Structure-Based Library Design in Efficient Discovery of Novel Inhibitors. Methods in molecular biology. 685. 175–190. 1 indexed citations
4.
Hamatake, Robert, Li‐Tain Yeh, Hong Kim, et al.. (2007). RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer. Molecular Cancer Therapeutics. 6. 3 indexed citations
5.
Cheney, I. Wayne, Shunqi Yan, T.C. Appleby, et al.. (2007). Identification and Structure—Activity Relationships of Substituted Pyridones as Inhibitors of Pim‐1 Kinase.. ChemInform. 38(30). 4 indexed citations
6.
Yan, Shunqi, et al.. (2007). Structure–activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(6). 1663–1666. 99 indexed citations
7.
Yan, Shunqi, T.C. Appleby, Gary Larson, et al.. (2007). Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study. Bioorganic & Medicinal Chemistry Letters. 17(7). 1991–1995. 44 indexed citations
8.
Cheney, I. Wayne, Shunqi Yan, T.C. Appleby, et al.. (2007). Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. Bioorganic & Medicinal Chemistry Letters. 17(6). 1679–1683. 148 indexed citations
9.
Yan, Shunqi, Gary Larson, Jim Zhen Wu, et al.. (2006). Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorganic & Medicinal Chemistry Letters. 17(1). 63–67. 46 indexed citations
10.
Larson, Gary, et al.. (2006). Identification of novel, selective and potent Chk2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(1). 172–175. 31 indexed citations
11.
Barawkar, Dinesh A., Subrata Chakravarty, Andreas Maderna, et al.. (2006). Identification of isothiazole-4-carboxamidines derivatives as a novel class of allosteric MEK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5561–5566. 20 indexed citations
12.
Yan, Shunqi, T.C. Appleby, Esmir Gunić, et al.. (2006). Isothiazoles as active-site inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 17(1). 28–33. 39 indexed citations
13.
Yan, Shunqi, T.C. Appleby, Gary Larson, et al.. (2006). Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(22). 5888–5891. 46 indexed citations
14.
15.
Moss, Robert A., et al.. (2001). SbF5-Mediated Reactions of Oxafluorodiazirines. Organic Letters. 3(15). 2305–2308. 9 indexed citations
16.
Moss, Robert A., et al.. (2001). Rearrangements of cyclopropylmethylchlorocarbene and dicyclopropylmethylchlorocarbene. Tetrahedron Letters. 42(51). 8923–8926. 3 indexed citations
17.
Li, Chuan, Mao‐Jung Lee, Shuqun Sheng, et al.. (2000). Structural Identification of Two Metabolites of Catechins and Their Kinetics in Human Urine and Blood after Tea Ingestion. Chemical Research in Toxicology. 13(3). 177–184. 221 indexed citations
18.
Moss, Robert A. & Shunqi Yan. (1999). Remote Substituent Effects on Phenylchlorocarbene C−H Insertion Reactions. Organic Letters. 1(5). 819–822. 3 indexed citations
19.
Yan, Shunqi, Ronald R. Sauers, & Robert A. Moss. (1999). Computational Studies of Oxahalocarbene Fragmentation:  Convergence of Theory and Experiment. Organic Letters. 1(10). 1603–1606. 15 indexed citations
20.
Moss, Robert A., Shunqi Yan, & Karsten Krogh‐Jespersen. (1998). Modulation of Carbenic Reactivity by π-Complexation to Aromatics. Journal of the American Chemical Society. 120(5). 1088–1089. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E H Ulm Breakdown of academic impact, for papers by Christine Luong Breakdown of academic impact, for papers by Weige Zhang Breakdown of academic impact, for papers by F. George Njoroge Breakdown of academic impact, for papers by Sankar Bhattacharyya Breakdown of academic impact, for papers by Antonietta Di Cristina Breakdown of academic impact, for papers by Weiren Xu Breakdown of academic impact, for papers by Rayomand J. Unwalla Breakdown of academic impact, for papers by Kunal Nepali Breakdown of academic impact, for papers by Torsten Herbertz
Rankless by CCL
2026